The effect of decontamination procedures on the pharmacodynamics of venlafaxine in overdose

British Journal of Clinical Pharmacology

Volumn 72, Issue 1, 2011, Pages 125-132

  Kumar, Venkata V Pavan ^a   Isbister, Geoffrey K ^b   Duffull, Stephen B ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Bayesian analysis; Overdose; Pharmacodynamics; Venlafaxine

Indexed keywords

ACTIVATED CARBON; VENLAFAXINE;

ADULT; ARTICLE; BAYES THEOREM; COHORT ANALYSIS; CONTROLLED STUDY; DRUG OVERDOSE; FEMALE; HUMAN; INTESTINE LAVAGE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MODEL; PRIORITY JOURNAL; PROBABILITY; SEIZURE; SIMULATION;

ADULT; ANTIDOTES; BAYES THEOREM; BIOLOGICAL AVAILABILITY; CHARCOAL; COHORT STUDIES; CYCLOHEXANOLS; DECONTAMINATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LOGISTIC MODELS; MALE; METABOLIC CLEARANCE RATE; OVERDOSE; SEIZURES; SEROTONIN UPTAKE INHIBITORS; THERAPEUTIC IRRIGATION; TIME FACTORS;

EID: 79958714145     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2011.03934.x     Document Type: Article

References (15)

1. Kapur N, House A, Creed F, Feldman E, Friedman T, Guthrie E. Management of deliberate self poisoning in adults in four teaching hospitals: descriptive study. Br Med J 1998; 316: 831-2.
2. Skegg K. Self-harm. Lancet 2005; 366: 1471-83.
3. Hawton K, Haigh R, Simkin S, Fagg J. Attempted suicide in Oxford University students, 1976-1990. Psychol Med 1995; 25: 179-88.
4. Kumar VV, Oscarsson S, Friberg LE, Isbister GK, Hackett LP, Duffull SB. The effect of decontamination procedures on the pharmacokinetics of venlafaxine in overdose. Clin Pharmacol Ther 2009; 86: 403-10.
5. Whyte IM, Dawson AH, Buckley NA. Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants. Q J Med 2003; 96: 369-74.
6. Isbister GK. Electrocardiogram changes and arrhythmias in venlafaxine overdose. Br J Clin Pharmacol 2009; 67: 572-6.
7. Buckley NA, McManus PR. Fatal toxicity of serotoninergic and other antidepressant drugs: analysis of United Kingdom mortality data. Br Med J 2002; 325: 1332-3.
8. Chyka PA, Seger D. Position statement: single-dose activated charcoal. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol 1997; 35: 721-41.
9. Friberg LE, Isbister GK, Duffull SB. Pharmacokinetic-pharmacodynamic modelling of QT interval prolongation following citalopram overdoses. Br J Clin Pharmacol 2006; 61: 177-90.
10. Isbister GK, Friberg LE, Stokes B, Buckley NA, Lee C, Gunja N, Brown SG, MacDonald E, Graudins A, Holdgate A, Duffull SB. Activated charcoal decreases the risk of QT prolongation after citalopram overdose. Ann Emerg Med 2007; 50: 593-600, 00 e1-46.
11. Spiegelhalter DJ, Thomas A, Best N, Lunn D. WinBUGS User Manual Version 1.4. London: Imperial College School of Medicine, 2003.
12. Vajjah VPK, Duffull SB. Novel Graphical Diagnostics for Assessing fit of Logistic Regression Models. PAGE 18 (2009) Abstr 1457. Available at (last accessed 7 March 2011).
13. Collet D. Modelling Survival Data in Medical Research. London: Chapman & Hill, 1994.
14. Gieser WP, Chang NM, Rao PV, Shuster JJ, Pullen J. Modelling cure rates using the Gompertz model with covariate information. Stat Med 1998; 17: 831-9.
15. Isbister GK, Balit CR, Whyte IM, Dawson A. Valproate overdose: a comparative cohort study of self poisonings. Br J Clin Pharmacol 2003; 55: 398-404.